Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.
about
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Long-term efficacy and safety ...... randomized phase 2 BOLT study.
@en
type
label
Long-term efficacy and safety ...... randomized phase 2 BOLT study.
@en
prefLabel
Long-term efficacy and safety ...... randomized phase 2 BOLT study.
@en
P2093
P2860
P356
P1476
Long-term efficacy and safety ...... randomized phase 2 BOLT study.
@en
P2093
A Guminski
A L S Chang
A Stratigos
P2860
P304
P356
10.1111/JDV.14542
P577
2017-11-06T00:00:00Z